See more : RTW Venture Fund Limited (RTW.L) Income Statement Analysis – Financial Results
Complete financial analysis of Anuh Pharma Limited (ANUHPHR.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Anuh Pharma Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Emova Group SA (ALEMV.PA) Income Statement Analysis – Financial Results
- Monarch Mining Corporation (GBAR.TO) Income Statement Analysis – Financial Results
- Cia de Ferro Ligas da Bahia – FERBASA (FESA4.SA) Income Statement Analysis – Financial Results
- Perion Network Ltd. (PERI) Income Statement Analysis – Financial Results
- Shagrir Group Vehicle Services Ltd (SHGR.TA) Income Statement Analysis – Financial Results
Anuh Pharma Limited (ANUHPHR.BO)
About Anuh Pharma Limited
Anuh Pharma Ltd. engages in the manufacture of pharmaceuticals, medicinal chemical, and botanical products. It also produces macrolides, anti-TB, anti-bacterial, anti-malaria, and corticosteroids products. The company was founded on February 19, 1960 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.47B | 5.27B | 4.87B | 4.32B | 3.07B | 3.21B | 2.38B | 2.06B | 3.26B | 2.84B | 2.66B | 2.43B | 2.26B | 1.76B | 1.65B | 1.21B | 1.11B | 817.73M |
| Cost of Revenue | 4.87B | 4.01B | 3.78B | 3.30B | 2.30B | 2.43B | 1.81B | 1.51B | 2.49B | 2.22B | 2.14B | 2.00B | 1.89B | 1.48B | 1.48B | 1.02B | 957.27M | 678.43M |
| Gross Profit | 1.60B | 1.26B | 1.09B | 1.02B | 767.97M | 777.25M | 572.96M | 555.33M | 775.52M | 621.79M | 521.24M | 425.87M | 369.75M | 279.47M | 166.87M | 188.79M | 151.44M | 139.31M |
| Gross Profit Ratio | 24.78% | 23.89% | 22.39% | 23.65% | 25.02% | 24.24% | 24.07% | 26.94% | 23.77% | 21.92% | 19.57% | 17.55% | 16.38% | 15.92% | 10.14% | 15.67% | 13.66% | 17.04% |
| Research & Development | 36.69M | 34.34M | 30.17M | 31.12M | 30.04M | 30.95M | 28.89M | 26.43M | 4.72M | 3.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 19.62M | 14.67M | 13.28M | 13.76M | 12.65M | 12.59M | 10.12M | 8.92M | 10.61M | 7.62M | 8.22M | 6.71M | 5.75M | 67.21M | 65.27M | 53.87M | 56.31M | 42.58M |
| Selling & Marketing | 16.08M | 10.79M | 7.95M | 6.62M | 8.53M | 11.03M | 6.72M | 4.98M | 4.52M | 5.98M | 4.28M | 5.16M | 3.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 35.70M | 25.46M | 21.22M | 20.38M | 21.18M | 23.62M | 16.84M | 13.90M | 15.13M | 13.60M | 12.50M | 11.87M | 9.43M | 67.21M | 65.27M | 53.87M | 56.31M | 42.58M |
| Other Expenses | 1.57B | 629.00K | 496.00K | 803.00K | 1.78M | 1.15M | 1.49M | 2.08M | 4.25M | 2.87M | 4.76M | 1.70M | 1.34M | 1.23M | 944.86K | 7.98M | 2.11M | 447.70K |
| Operating Expenses | 1.60B | 815.55M | 717.61M | 716.93M | 532.45M | 447.85M | 369.24M | 347.27M | 396.68M | 316.08M | 259.93M | 240.05M | 165.67M | 126.64M | -9.76M | 47.57M | 34.72M | 33.61M |
| Cost & Expenses | 5.79B | 4.83B | 4.49B | 4.01B | 2.83B | 2.88B | 2.18B | 1.85B | 2.88B | 2.53B | 2.40B | 2.24B | 2.05B | 1.60B | 1.47B | 1.06B | 991.99M | 712.04M |
| Interest Income | 11.73M | 4.50M | 10.45M | 6.95M | 4.69M | 4.67M | 4.42M | 7.70M | 13.32M | 14.56M | 15.95M | 13.37M | 7.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.57M | 2.18M | 9.61M | 14.95M | 7.92M | 1.71M | 405.00K | 354.00K | 273.99K | 311.92K | 562.46K | 453.44K | 544.79K | 1.31M | 1.11M | 8.33M | 2.31M | 563.47K |
| Depreciation & Amortization | 85.84M | 97.00M | 119.60M | 150.76M | 70.33M | 16.62M | 18.32M | 19.68M | 22.59M | 32.74M | 17.46M | 16.64M | 13.22M | 11.07M | 11.58M | 11.22M | 10.66M | 12.28M |
| EBITDA | 872.47M | 579.17M | 526.62M | 556.57M | 274.46M | 346.62M | 257.00M | 302.74M | 410.61M | 360.80M | 273.27M | 193.94M | 195.71M | -1.60B | 188.05M | 151.64M | 126.80M | 117.67M |
| EBITDA Ratio | 13.48% | 10.05% | 10.14% | 11.00% | 9.62% | 10.22% | 10.47% | 12.97% | 12.29% | 11.60% | 9.74% | 7.96% | 8.18% | -91.29% | 11.43% | 12.62% | 11.47% | 14.41% |
| Operating Income | 682.20M | 450.41M | 377.60M | 309.81M | 238.54M | 335.15M | 196.81M | 213.90M | 323.69M | 296.27M | 241.91M | 176.47M | 171.40M | -1.61B | 176.47M | 140.88M | 116.53M | 105.58M |
| Operating Income Ratio | 10.54% | 8.54% | 7.76% | 7.17% | 7.77% | 10.45% | 8.27% | 10.38% | 9.92% | 10.44% | 9.08% | 7.27% | 7.59% | -91.92% | 10.72% | 11.69% | 10.51% | 12.91% |
| Total Other Income/Expenses | 100.90M | 24.29M | 13.62M | 75.70M | -43.96M | -5.38M | 30.45M | 67.80M | 531.75K | 12.89M | -6.54M | -8.97M | 9.10M | 31.60M | -1.28M | -8.67M | -2.50M | -679.25K |
| Income Before Tax | 783.10M | 474.70M | 391.22M | 385.51M | 191.56M | 324.01M | 234.17M | 275.86M | 379.37M | 318.61M | 254.76M | 176.85M | 180.50M | 175.08M | 175.35M | 132.55M | 114.22M | 105.01M |
| Income Before Tax Ratio | 12.10% | 9.00% | 8.04% | 8.92% | 6.24% | 10.10% | 9.84% | 13.38% | 11.63% | 11.23% | 9.56% | 7.29% | 8.00% | 9.97% | 10.66% | 11.00% | 10.30% | 12.84% |
| Income Tax Expense | 182.52M | 112.91M | 85.61M | 101.15M | 48.50M | 90.35M | 69.05M | 75.35M | 121.33M | 98.69M | 78.87M | 51.50M | 52.04M | 52.26M | 50.06M | 45.73M | 36.58M | 36.24M |
| Net Income | 600.58M | 361.80M | 305.61M | 284.36M | 143.05M | 233.66M | 165.12M | 200.51M | 258.04M | 219.91M | 175.90M | 125.35M | 128.46M | 122.90M | 125.47M | 87.16M | 77.84M | 68.89M |
| Net Income Ratio | 9.28% | 6.86% | 6.28% | 6.58% | 4.66% | 7.29% | 6.94% | 9.73% | 7.91% | 7.75% | 6.60% | 5.17% | 5.69% | 7.00% | 7.62% | 7.23% | 7.02% | 8.42% |
| EPS | 11.98 | 7.22 | 6.10 | 5.67 | 2.85 | 4.66 | 3.30 | 4.00 | 5.15 | 4.39 | 3.51 | 2.50 | 2.56 | 2.45 | 2.50 | 1.74 | 1.55 | 1.37 |
| EPS Diluted | 11.98 | 7.22 | 6.10 | 5.67 | 2.85 | 4.66 | 3.30 | 4.00 | 5.15 | 4.39 | 3.51 | 2.50 | 2.56 | 2.45 | 2.50 | 1.74 | 1.55 | 1.37 |
| Weighted Avg Shares Out | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M |
| Weighted Avg Shares Out (Dil) | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M | 50.11M |
No news found for: ANUHPHR.BO
Source: https://incomestatements.info
Category: Stock Reports